Bibliometric Analysis of Research on Traditional Chinese Medicine Treatment of Myocardial Infarction from 2007 to 2024 Based on the Web of Science Database.
Qi Lan, Hao Wu, Ming-Tai Chen, Jin-Yi Xue, Maryam Mazhar, Zi-Wen Deng, Yuan Zou, Ping Liu, Gang Luo, Li Dong, Meng-Nan Liu
{"title":"Bibliometric Analysis of Research on Traditional Chinese Medicine Treatment of Myocardial Infarction from 2007 to 2024 Based on the Web of Science Database.","authors":"Qi Lan, Hao Wu, Ming-Tai Chen, Jin-Yi Xue, Maryam Mazhar, Zi-Wen Deng, Yuan Zou, Ping Liu, Gang Luo, Li Dong, Meng-Nan Liu","doi":"10.2174/0109298673362741250128065027","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Myocardial infarction (MI) is a common critical syndrome in the late development of cardiovascular diseases (CVDs), and traditional Chinese Medicine (TCM) treatment has become an essential branch in this field.</p><p><strong>Objective: </strong>This study aimed to use bibliometric methods to examine the research trajectory of TCM treatment of MI from 2007 to 2024 from a multidimensional perspective and analyse its characteristics, hotspots, and frontiers.</p><p><strong>Methods: </strong>This study used the search formula TS OR TI OR AB OR A (\"traditional Chinese medicine\" or \"Chinese medicine\" or \"TCM\" or \"traditional medicine, Chinese\" or \" Chinese traditional medicine\" or \"Chinese medicine, traditional\") AND TS OR TI OR AB OR AK (\"myocardial infarction\" or \"myocardial infarctions\" or \" infarction, myocardial\" or \"infarctions, myocardial\" or \"myocardial infarct\" or \"MI\") to find the Web of Science Core Collection (WOSCC) of relevant studies from 01/01/2007 to 04/29/2024. Target literature records were analysed and graphed using CiteSpace, VOSviewer, and Scimago Graphica.</p><p><strong>Results: </strong>A total of 754 records were obtained and 399 records were finally retained after screening. Countries, institutions, authors, and journals were visually analyzed. The current research hotspots and frontiers included Salvia miltiorrhiza, ischemia-reperfusion injury, pathway, molecular docking, and network pharmacology.</p><p><strong>Conclusion: </strong>This research study would enrich the researchers' understanding of the existing research methodology and future development trends and provide a more efficient research methodology for the research on the mechanism of action of TCM for the treatment of MI and its clinical trials.</p>","PeriodicalId":10984,"journal":{"name":"Current medicinal chemistry","volume":" ","pages":"438-460"},"PeriodicalIF":3.5000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0109298673362741250128065027","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Myocardial infarction (MI) is a common critical syndrome in the late development of cardiovascular diseases (CVDs), and traditional Chinese Medicine (TCM) treatment has become an essential branch in this field.
Objective: This study aimed to use bibliometric methods to examine the research trajectory of TCM treatment of MI from 2007 to 2024 from a multidimensional perspective and analyse its characteristics, hotspots, and frontiers.
Methods: This study used the search formula TS OR TI OR AB OR A ("traditional Chinese medicine" or "Chinese medicine" or "TCM" or "traditional medicine, Chinese" or " Chinese traditional medicine" or "Chinese medicine, traditional") AND TS OR TI OR AB OR AK ("myocardial infarction" or "myocardial infarctions" or " infarction, myocardial" or "infarctions, myocardial" or "myocardial infarct" or "MI") to find the Web of Science Core Collection (WOSCC) of relevant studies from 01/01/2007 to 04/29/2024. Target literature records were analysed and graphed using CiteSpace, VOSviewer, and Scimago Graphica.
Results: A total of 754 records were obtained and 399 records were finally retained after screening. Countries, institutions, authors, and journals were visually analyzed. The current research hotspots and frontiers included Salvia miltiorrhiza, ischemia-reperfusion injury, pathway, molecular docking, and network pharmacology.
Conclusion: This research study would enrich the researchers' understanding of the existing research methodology and future development trends and provide a more efficient research methodology for the research on the mechanism of action of TCM for the treatment of MI and its clinical trials.
背景:心肌梗死(MI)是心血管疾病(cvd)晚期常见的危重综合征,中医治疗已成为该领域的一个重要分支。目的:运用文献计量学方法,从多维角度考察2007 - 2024年中医药治疗心肌梗死的研究轨迹,分析其特点、热点和前沿。方法:本研究使用检索公式TS OR TI OR AB OR A(“traditional Chinese medicine”或“Chinese medicine”或“traditional medicine, Chinese”或“Chinese traditional medicine, Chinese”或“Chinese traditional medicine, Chinese”或“Chinese traditional medicine, Chinese”或“Chinese traditional medicine”或“Chinese中医药”或“Chinese medicine, Chinese medicine”或“Chinese medicine, traditional”)和TS OR TI OR AB OR AK(“myocardial infarction”或“infarction, myocardial”或“infarction, myocardial”或“infarction, myocardial”或“myocardial梗死,myocardial”或“myocardial infarction”或“myocardial infarction”或“myocardial infarction”或“myocardial infarction”或“心肌梗死”或“myocardial infarction”或“心肌梗死”或“心肌梗死”或“心肌梗死”或“心肌梗死”或“心肌梗死”或“心肌梗死”或“心肌梗死”或“心肌梗死”或“MI”)检索2007年1月1日至2024年4月29日的相关研究Web of Science Core Collection (WOSCC)。使用CiteSpace、VOSviewer和Scimago Graphica对目标文献记录进行分析和绘图。结果:经筛选,共获得754条记录,最终保留399条记录。对国家、机构、作者和期刊进行了可视化分析。目前的研究热点和前沿包括丹参、缺血再灌注损伤、通路、分子对接、网络药理学等。结论:本研究将丰富研究者对现有研究方法和未来发展趋势的认识,为中药治疗心肌梗死的作用机制研究及临床试验提供更有效的研究方法。
期刊介绍:
Aims & Scope
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.